Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02358564 · ClinicalTrials.gov registry record · NA

Gut Permeability, Sensitivity and Symptomatology

A NA study of Irritable Bowel Syndrome and Visceral Hypersensitivity, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
39
Enrollment target
2
Study locations

NCT02358564: Completed NA study of Irritable Bowel Syndrome and Visceral Hypersensitivity, sponsored by Mayo Clinic.

NCT02358564 is a NA study of Irritable Bowel Syndrome and Visceral Hypersensitivity that has completed, run by Mayo Clinic. The registered enrollment target is 39 participants, below the 143-participant average among 47 other Irritable Bowel Syndrome trials with a reported enrollment target (73% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02358564, a NA study of Irritable Bowel Syndrome and Visceral Hypersensitivity, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
39 participants
Enrollment target
2
Study locations

Study Summary

To better understand the relationship between gut barrier function and the symptomatology and pathophysiology of irritable bowel syndrome (IBS).

Conditions Studied

Irritable Bowel Syndrome Visceral Hypersensitivity

Interventions

  • PROCEDURE Gastrointestinal Permeability Test
  • PROCEDURE Upper Endoscopy
  • PROCEDURE Rectal Barostat and Infusion of Fats

Study Locations (2)

Florida

  • Mayo Clinic in Florida - Jacksonville

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 39 participants
Start Date 2015-02
Est. Completion 2021-03-11
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02358564

The ClinicalTrials.gov registry entry for NCT02358564 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 143-participant average among 47 other Irritable Bowel Syndrome trials with a reported enrollment target (73% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Irritable Bowel Syndrome appearing as the primary indexed condition, and to 3 interventions - of which Gastrointestinal Permeability Test is the first listed.

NCT02358564 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Florida, Minnesota.

Frequently Asked Questions

What is clinical trial NCT02358564 about?

NCT02358564 is a clinical study titled "Gut Permeability, Sensitivity and Symptomatology". To better understand the relationship between gut barrier function and the symptomatology and pathophysiology of irritable bowel syndrome (IBS).

What is the current status of trial NCT02358564?

This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2015-02. Estimated completion is 2021-03-11.

What conditions does trial NCT02358564 study?

This clinical trial studies the following conditions: Irritable Bowel Syndrome, Visceral Hypersensitivity.

What interventions are being tested in trial NCT02358564?

The interventions under investigation include: Gastrointestinal Permeability Test (PROCEDURE), Upper Endoscopy (PROCEDURE), Rectal Barostat and Infusion of Fats (PROCEDURE).

Who is sponsoring clinical trial NCT02358564?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02358564 being conducted?

This trial has 2 study locations across Florida, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Irritable Bowel Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Irritable Bowel Syndrome

All registered trials for this condition

Visceral Hypersensitivity

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.